Start with the decisions your organisation needs to make
Choosing a consulting partner is easier when you can explain what needs to change. You may be preparing for growth, reviewing responsibilities across teams, responding to recurring operational problems or deciding where to invest in your safety function.
Pharmacovigilance Consulting can help bring these priorities together. A useful engagement should connect specialist advice with decisions your organisation can act on.
Step 1: Define your priorities and intended outcomes
Prepare a short brief describing your current situation, the problems you want to solve and the outcomes you need.
Include:
- Your product portfolio and development or commercial stage.
- The markets and organisational functions involved.
- The main operational, governance or capability concerns.
- Any important business milestones or dependencies.
- What successful delivery would look like.
For example, “improve pharmacovigilance” is difficult to scope. “Clarify responsibilities between our central team and regional partners before portfolio expansion” gives a prospective partner a more useful starting point.
Step 2: Identify the type of support you need
Different challenges require different expertise. If your main concern is ownership, workflow or vendor oversight, Pharmacovigilance Management Consulting may be the most relevant starting point.
If you need an objective view of performance and maturity before deciding what to change, Pharmacovigilance Benchmarking can help establish priorities.
Explain the problem first, then agree the appropriate mix of services.
Step 3: Assess relevant experience
Ask who will deliver the work and how their experience relates to your organisation. Relevant experience may involve similar product types, operating models, growth stages or geographic responsibilities.
Request examples of the problems they have addressed, the work they performed and how recommendations were implemented. An anonymised example can still demonstrate a clear method and practical understanding.
Step 4: Examine the proposed approach
A strong proposal should explain how the partner will gather evidence, involve stakeholders, assess findings and develop recommendations.
Check whether the engagement includes implementation support, knowledge transfer or follow-up assessment. Where changing requirements are a key concern, discuss how Regulatory Intelligence will inform the work.
Step 5: Agree scope, responsibilities and deliverables
Confirm what is included, what your team must provide and who will approve each deliverable. Specify the expected level of detail and how recommendations will be prioritised.
Useful deliverables might include an assessment report, an improvement roadmap, an operating model or a training plan. Their value depends on whether your team can use them to make decisions and deliver change.
Step 6: Plan implementation from the outset
Agree who will own each improvement after the assessment. Allow time for procedure updates, stakeholder communication and changes to everyday working practices.
Where employees need new skills or clearer understanding, Pharmacovigilance Training can support adoption. Define how you will check that improvements remain effective after the consulting engagement ends.
Frequently Asked Questions: Choosing a Pharmacovigilance Partner
Include your business context, product and market scope, current concerns, existing operating model and intended outcomes. Add relevant milestones and identify the internal people available to support the project. A concise, accurate brief is more useful than a large collection of unexplained documents.
Compare the proposed scope, delivery team, assessment method, deliverables and implementation support. Check the assumptions behind each price. Two proposals may appear similar while requiring very different levels of internal effort or providing different levels of follow-up support.
Ask how they would investigate your main challenge, which evidence they would need and how they would turn findings into action. Discuss who will lead the work, who will review it and how specialist questions will be handled.
Experience with a comparable organisation helps a partner understand your resource constraints and decision-making structure. However, the more important question is whether their proposed approach is proportionate to your complexity, risk and internal capability.
Choose a focused project when the problem and its boundaries are clear. Consider a broader review when issues affect several teams or when the underlying cause is uncertain. An initial discovery phase can help determine the appropriate scope.
A practical recommendation explains the issue, the action required, the intended outcome and the resources needed. It should identify an owner, dependencies and a way to evaluate effectiveness. Advice should be specific enough for your organisation to implement.
Use early discussions to explore communication, challenge and decision-making. Ask how the partner handles conflicting stakeholder views or incomplete information. Clear explanations and realistic expectations are useful indicators of a constructive working relationship.
Yes. Establish initial success measures during scoping, then refine them when the baseline is understood. Depending on the project, measures could include clearer ownership, fewer unresolved handoffs, improved action completion or adoption of agreed procedures.
Document the initial scope, assumptions, exclusions and deliverables. Agree a process for assessing new findings and approving additional work. Some changes may be justified, but their impact on cost, timing and internal resources should be transparent.
Review the findings, confirm ownership of outstanding actions and ensure knowledge has been transferred. Agree which improvements need follow-up and when their effectiveness will be assessed. The final handover should leave your team with a usable plan.
Discuss your pharmacovigilance priorities
Explore Qinecsa’s Pharmacovigilance Consulting services to discuss the support that best fits your organisation’s priorities, resources and stage of development.